Home » Topics » BioWorld Science

BioWorld Science
RSS

Chinese researchers patent adenosine A2A receptor antagonists

Oct. 11, 2018

Hypermethylation of miR-145-5p drives laryngeal squamous cell carcinoma invasion and metastasis

Oct. 11, 2018

R-DMDdel52, a new rat model of Duchenne muscular dystrophy, developed

Oct. 11, 2018

GS-6207 shows long-acting nonclinical pharmacokinetic profile

Oct. 11, 2018

PF-06939926 induces a greater amelioration of DMD pathology when administered at a younger age

Oct. 11, 2018

Urinary exosomal CCL-21 mRNA as marker of histological injury and renal function deterioration in DN

Oct. 11, 2018

The nitty gritty: Drilling down into sepsis shows routes to treatment

Oct. 11, 2018

Helix BioPharma, Moffitt Cancer Center expand collaboration

Oct. 11, 2018

U.S. DoD funding phase II combination study of TPIV-110 in breast cancer

Oct. 11, 2018

Hemispherx and Roswell Park enter clinical trial agreement to study Ampligen

Oct. 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...